Related Experiment Video
Updated: Nov 7, 2025
09:34
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
9.2K
Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
Tianqi Wang1, Yusuke Suita2, Saradha Miriyala2
1Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, USA.
Pharmaceutics
|April 30, 2021
Summary
Lipid-based nanoparticles show promise for combining chemotherapy and immunotherapy (chemoimmunotherapy) in cancer treatment. This review explores their potential, clinical trials, and challenges for wider application.
Area of Science:
- Oncology
- Nanomedicine
- Immunotherapy
Background:
- Nanomedicines offer significant potential in cancer therapy, particularly through chemoimmunotherapy.
- Lipid-based nanoparticles are a widely utilized nanomedicine platform for cancer treatment and a promising delivery system for chemoimmunotherapy.
- Most nanomedicines for chemoimmunotherapy are currently in preclinical and clinical trial stages.
Purpose of the Study:
- To review immunotherapy agents and opportunities for chemoimmunotherapy mediated by lipid-based nanoparticles.
- To summarize clinical trials involving lipid-based nanoparticles for chemoimmunotherapy.
- To highlight preclinical chemoimmunotherapy strategies using various lipid-based nanoparticle formulations.
Main Methods:
- Literature review of immunotherapy agents.
- Analysis of clinical trials for lipid-based nanomedicines in chemoimmunotherapy.
- Summary of preclinical research on liposomes, nanodiscs, and hybrid lipid nanoparticles for chemoimmunotherapy.
Main Results:
- Lipid-based nanoparticles are a versatile platform for delivering chemoimmunotherapy agents.
- Various lipid-based formulations like liposomes and nanodiscs show potential in preclinical studies.
- Several clinical trials are investigating lipid-based nanoparticles for chemoimmunotherapy.
Conclusions:
- Lipid-based nanoparticles represent a key strategy for advancing chemoimmunotherapy.
- Overcoming challenges in clinical translation is crucial for realizing the full potential of these nanomedicines.
- Future perspectives focus on optimizing delivery and efficacy for improved cancer treatment outcomes.
Related Concept Videos
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
01:27Tumor Immunotherapy
807
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
807
02:50Combination Therapies and Personalized Medicine
5.5K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K
01:30Cancer Vaccines
603
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
603
02:49Cancer Therapies
8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K